WHO Admits Everyone Who Receives a MonkeyPox Vaccine is Part of a "Clinical Trial" to Collect Data on its Effectiveness

WHO Admits Everyone Who Receives a Monkeypox Vaccine is Part of a "Clinical Trial" to Collect Data

• Tim Nguyen, the Unit Head of Global Infectious Hazards Preparedness at the World Health Organization Emergency Programme, said that the vaccine efficacy is yet unknown since it has never been used on this scale before.
• "And therefore, when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting data to increase our understanding of the effectiveness of these vaccines."

There are only two vaccines licensed by the U.S. Food and Drug Administration (FDA) available for "preventing monkeypox infection"

• JYNNEOS (also known as Imvamune or Imvanex) and ACAM2000
• WHO declared the monkeypox outbreak a global health emergency

Reports:

• Director-General Tedros overruled the decision of 8 members of the expert committee who voted against the declaration, only 6 are in favor

New York

• 26,000 additional doses of JYNNEOS vaccine were delivered to New York City as part of Phase 2b from the federal government and state
• distributed via clinics, mass vaccination sites and community-based referrals
• The Health Department is moving quickly to distribute as many vaccine doses as they can in the most equitable way possible 

https://www.thegatewaypundit.com/2022/07/admits-everyone-receives-monkeypox-vaccine-part-clinical-trial-collect-data-effectiveness-video/